Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not in primary tumours
Hi̇lal Özdağ(University of Cambridge), Carlos Caldas(University of Cambridge), Asta Försti(Lund University), Mark J. Arends(Edinburgh Cancer Research), Tony Kouzarides(The Gurdon Institute), Jonathan M. Boutell(University of Cambridge), Sarah J. Batley(University of Cambridge), Yataro Daigo(The University of Tokyo), B. A. J. Ponder, N. Gopalakrishna Iyer(Duke-NUS Medical School)
Cited by 61
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Regulation of chromatin by histone modifications
|Cell Research|2011|5.9k
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
|Nature|2011|1.5k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
Toward understanding and exploiting tumor heterogeneity
|Nature Medicine|2015|770